OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Antibody glycosylation: impact on antibody drug characteristics and quality control
Ziyan Wang, Jianwei Zhu, Huili Lu
Applied Microbiology and Biotechnology (2020) Vol. 104, Iss. 5, pp. 1905-1914
Closed Access | Times Cited: 49

Showing 1-25 of 49 citing articles:

The Dawn of a New Era: Targeting the “Undruggables” with Antibody-Based Therapeutics
Linghui Qian, Xuefen Lin, Xue Gao, et al.
Chemical Reviews (2023) Vol. 123, Iss. 12, pp. 7782-7853
Closed Access | Times Cited: 61

Engineering and emerging applications of artificial metalloenzymes with whole cells
Malte Wittwer, Ulrich Markel, Johannes Schiffels, et al.
Nature Catalysis (2021) Vol. 4, Iss. 10, pp. 814-827
Closed Access | Times Cited: 58

Immobilized enzyme cascade for targeted glycosylation
Elli Makrydaki, Roberto Donini, A. P. Krueger, et al.
Nature Chemical Biology (2024) Vol. 20, Iss. 6, pp. 732-741
Open Access | Times Cited: 11

LAP: Liability Antibody Profiler by sequence & structural mapping of natural and therapeutic antibodies
Tadeusz Satława, Mateusz Tarkowski, Sonia Wróbel, et al.
PLoS Computational Biology (2024) Vol. 20, Iss. 3, pp. e1011881-e1011881
Open Access | Times Cited: 6

Trends and Challenges in Bispecific Antibody Production
Mikhail S. Karbyshev, Irina Kalashnikova, Veronika Dubrovskaya, et al.
Journal of Chromatography A (2025), pp. 465722-465722
Closed Access

Antibody glycosylation in autoimmune diseases
Xing Zhou, Francesca Motta, Carlo Selmi, et al.
Autoimmunity Reviews (2021) Vol. 20, Iss. 5, pp. 102804-102804
Open Access | Times Cited: 41

Developability assessment at early-stage discovery to enable development of antibody-derived therapeutics
Weijie Zhang, Hao Wang, Nan Feng, et al.
Antibody Therapeutics (2022) Vol. 6, Iss. 1, pp. 13-29
Open Access | Times Cited: 26

Applications of capillary electrophoresis for biopharmaceutical product characterization
Ramesh Kumar, András Guttman, Anurag S. Rathore
Electrophoresis (2021) Vol. 43, Iss. 1-2, pp. 143-166
Closed Access | Times Cited: 33

A novel sustainable immunoassay for sensitive detection of atrazine based on the anti-idiotypic nanobody and recombinant full-length antibody
Jing Zhao, Peipei Li, A.M. Abd El‐Aty, et al.
Chemical Engineering Journal (2024) Vol. 491, pp. 152039-152039
Closed Access | Times Cited: 4

From cell line development to the formulated drug product: The art of manufacturing therapeutic monoclonal antibodies
Stefania Carrara, Michael Ulitzka, Julius Grzeschik, et al.
International Journal of Pharmaceutics (2020) Vol. 594, pp. 120164-120164
Closed Access | Times Cited: 36

Platform-Specific Fc N-Glycan Profiles of an Antisperm Antibody
Ellena Nador, Chaoshuang Xia, Philip J. Santangelo, et al.
Antibodies (2024) Vol. 13, Iss. 1, pp. 17-17
Open Access | Times Cited: 2

Recent Advances in Biologic Therapeutic N-Glycan Preparation Techniques and Analytical Methods for Facilitating Biomanufacturing Automation
Erin K. Tiwold, Aron Gyorgypal, Shishir P. S. Chundawat
Journal of Pharmaceutical Sciences (2023) Vol. 112, Iss. 6, pp. 1485-1491
Open Access | Times Cited: 7

Antibodies against Anthrax Toxins: A Long Way from Benchlab to the Bedside
Arnaud Avril, Jean‐Nicolas Tournier, Jean-Charles Paucod, et al.
Toxins (2022) Vol. 14, Iss. 3, pp. 172-172
Open Access | Times Cited: 12

Process- and Product-Related Foulants in Virus Filtration
Solomon Isu, Xianghong Qian, Andrew L. Zydney, et al.
Bioengineering (2022) Vol. 9, Iss. 4, pp. 155-155
Open Access | Times Cited: 11

Functional production of human antibody by the filamentous fungus Aspergillus oryzae
Hung Hiep Huynh, Naoki Morita, Toshihiro Sakamoto, et al.
Fungal Biology and Biotechnology (2020) Vol. 7, Iss. 1
Open Access | Times Cited: 17

High-affinity recombinant full-length antibody-based immunochromatographic strip assay for rapid and reliable detection of pyraclostrobin residues in food samples
Ying Liu, Shasha Jiao, Yunyun Chang, et al.
Food and Agricultural Immunology (2020) Vol. 31, Iss. 1, pp. 985-1003
Open Access | Times Cited: 17

N-Glycosylated Ganoderma lucidum immunomodulatory protein improved anti-inflammatory activity via inhibition of the p38 MAPK pathway
Qizhang Li, Xin Chen, Pei-Wen Mao, et al.
Food & Function (2021) Vol. 12, Iss. 8, pp. 3393-3404
Closed Access | Times Cited: 15

Physiological and Pathological Inflammation Induced by Antibodies and Pentraxins
Chiara E. Geyer, Lynn Mes, Melissa Newling, et al.
Cells (2021) Vol. 10, Iss. 5, pp. 1175-1175
Open Access | Times Cited: 15

Optimized Methods for Analytical and Functional Comparison of Biosimilar mAb Drugs: A Case Study for Avastin, Mvasi, and Zirabev
Büşra Gürel, Eda Çapkın, Ayhan Parlar, et al.
Scientia Pharmaceutica (2022) Vol. 90, Iss. 2, pp. 36-36
Open Access | Times Cited: 10

Enzymatic Synthesis of Glycans and Glycoconjugates
Thomas Rexer, Dominic Laaf, Johannes Gottschalk, et al.
Advances in biochemical engineering, biotechnology (2020), pp. 231-280
Closed Access | Times Cited: 15

Strategic feeding of NS0 and CHO cell cultures to control glycan profiles and immunogenic epitopes of monoclonal antibodies
Carina Villacrés, Venkata S. Tayi, Michael Butler
Journal of Biotechnology (2021) Vol. 333, pp. 49-62
Closed Access | Times Cited: 12

Recombinant antibodies aggregation and overcoming strategies in CHO cells
Tingting Xu, Jihong Zhang, Tianyun Wang, et al.
Applied Microbiology and Biotechnology (2022) Vol. 106, Iss. 11, pp. 3913-3922
Closed Access | Times Cited: 7

Development of a Non-IgG PD-1/PD-L1 Inhibitor by in Silico Mutagenesis and an In-Cell Protein–Protein Interaction Assay
Boyang Ning, Xueli Ren, Kyoji Hagiwara, et al.
ACS Chemical Biology (2021) Vol. 16, Iss. 2, pp. 316-323
Closed Access | Times Cited: 8

The Mannose in the Mirror: A Reflection on the Pharmacokinetic Impact of High Mannose Glycans of Monoclonal Antibodies in Biosimilar Development
Joel Welch, Cristina Ausín, Nina N. Brahme, et al.
Clinical Pharmacology & Therapeutics (2022) Vol. 113, Iss. 5, pp. 1003-1010
Closed Access | Times Cited: 5

Optimization strategies for expression of a novel bifunctional anti-PD-L1/TGFBR2-ECD fusion protein
Zhangzhao Gao, Cui Li, Gang Chen, et al.
Protein Expression and Purification (2021) Vol. 189, pp. 105973-105973
Closed Access | Times Cited: 7

Page 1 - Next Page

Scroll to top